Questions answered
- How should EBITDA be normalised?
- What if comparables are scarce?
- How should downside be tested?
The problem
Overpayment is not only about a high multiple. It is paying a price that fails after earnings normalisation, working-capital needs, sustaining CAPEX, financing cost or a less favourable operating case.
DealPME does not issue a formal valuation opinion in the governed perimeter. This playbook teaches price discipline and the questions to take to a qualified valuation or financial adviser.
Step 1 : Define what the price represents
Separate enterprise value, equity value, debt, cash, working capital, non-operating items and transaction costs. Multiple comparisons are meaningless if bases differ.
Step 2 : Normalise EBITDA / cash flow
List every adjustment: owner pay, related parties, unusual costs, non-recurring revenue, costs that return, subsidies, underinvestment and FX. Each adjustment needs evidence and a status: ACCEPT, REJECT, PARTIAL, PRO_REVIEW.
Step 3 : Test cash conversion
EBITDA is not cash. Review tax, working capital, sustaining CAPEX, debt service, seasonality and growth needs.
Step 4 : Use comparables cautiously
IVS provides a framework for valuation approaches and data. Where comparable data are scarce, do not invent a local multiple. Document size, country, sector, growth, margin, control, date, liquidity and data quality.
Step 5 : Build downside cases
At minimum: revenue decline, margin compression, higher working capital, unexpected CAPEX, delayed integration and higher debt cost.
Step 6 : Test financing capacity
A price can appear acceptable at equity value while creating fragile debt. Test lender metrics/headroom, minimum cash and reserves.
Step 7 : Review terms, not only price
Deferred consideration, earn-out, seller finance, warranties, partner escrow, rollover equity and conditions redistribute risk between parties.
Valuation Sanity Check
| Test | Base case | Downside | Evidence | Question |
|---|---|---|---|---|
| Normalized EBITDA | are adjustments robust? | |||
| Cash conversion | cash after WC/CAPEX? | |||
| Debt capacity | lender case survives? | |||
| Customer concentration | revenue at risk? | |||
| Owner dependency | transition cost/time? | |||
| Implied multiple | comparable evidence? | |||
| Equity headroom | reserve after close? |
Stop conditions
Unsupported EBITDA adjustments, insufficient cash after CAPEX/WC, financing that only works in the optimistic case, weak comparable evidence, undefined debt/cash/WC, a price justified only by an unsourced “market multiple”, or dependence on immediate hypothetical refinancing.
Deal-Pricer boundary
Under the conditional architecture, Deal-Pricer may provide an indicative range with visible method and sources. It must never be described as a formal DealPME valuation opinion.
Professional escalation
Where price is material, complex, contested, tax-sensitive or used by a financier, use a qualified valuation/financial professional and document scope, basis of value, methods, assumptions and limitations.
<!-- ENHANCEMENT_V2 -->
Build the enterprise-value to equity-value bridge
Explicitly document enterprise value, included/excluded debt, cash, cash-like/debt-like items, working-capital target, specific provisions, transaction costs and non-operating items. Each item needs a contractual definition or open question.
Comparable Evidence Checklist
For each comparable record source, date, country, sector, size, growth, margin, control, transaction type, metric, data quality and required adjustments. If those fields are unknown, the multiple has limited evidential value.
Funding-price feedback loop
After every material price or structure change, recalculate sources & uses, debt service, minimum cash and downside. Price should not live in one model while financing lives in another.
Walk-away discipline
Before the offer, define conditions that make economics incoherent: insufficient cash flow, fragile leverage, hidden CAPEX, unresolved dependency, missing management or blocking regulatory risk. These are guardrails, not a universal formula.
Mini-FAQ
Can I apply a multiple from a nearby transaction? Only after analysing comparability and calculation basis. A context-free multiple is not valuation evidence.
Should I set one maximum price? You can set economic discipline, but deferred consideration, earn-out or seller finance can change risk and therefore real economics.
Sources
Ranked by authority. Links open the publisher's site.
- Reference International Valuation Standards
This resource explains; it is neither legal, tax or financial advice nor a formal valuation. Have your situation validated by a professional.

